S9C

7-(6-fluoranylpyridin-3-yl)-5~{H}-pyrido[4,3-b]indole

Created:	2022-12-14
Last modified:	2023-01-11

Find Related PDB Entry
1 entries where S9C is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	30
Chiral Atom Count	0
Bond Count	33
Aromatic Bond Count	21

2D diagram of S9C

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	7-(6-fluoranylpyridin-3-yl)-5~{H}-pyrido[4,3-b]indole
Systematic Name (OpenEye OEToolkits)	7-(6-fluoranylpyridin-3-yl)-5~{H}-pyrido[4,3-b]indole
Formula	C₁₆ H₁₀ F N₃
Molecular Weight	263.269
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	CACTVS	3.385	Fc1ccc(cn1)c2ccc3c([nH]c4ccncc34)c2
SMILES	OpenEye OEToolkits	3.1.0.0	c1cc2c(cc1c3ccc(nc3)F)[nH]c4c2cncc4
Canonical SMILES	CACTVS	3.385	Fc1ccc(cn1)c2ccc3c([nH]c4ccncc34)c2
Canonical SMILES	OpenEye OEToolkits	3.1.0.0	c1cc2c(cc1c3ccc(nc3)F)[nH]c4c2cncc4
InChI	InChI	1.06	InChI=1S/C16H10FN3/c17-16-4-2-11(8-19-16)10-1-3-12-13-9-18-6-5-14(13)20-15(12)7-10/h1-9,20H
InChIKey	InChI	1.06	GETAAWDSFUCLBS-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank ID	DB15033
Name	Flortaucipir
Groups	investigational
Description	Flortaucipir is under investigation in clinical trial NCT03507257 (Longitudinal Early-onset Alzheimer's Disease Study Protocol).
Synonyms	Flortaucipir
Categories	Compounds used in a research, industrial, or household setting Contrast Media Diagnostic Uses of Chemicals Heterocyclic Compounds, Fused-Ring Indole Alkaloids Indoles Pyridines
CAS number	1415379-56-4

Related Resource References

Resource Name	Reference
PubChem	71059746
ChEMBL	CHEMBL3546271

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.